New strategies in ovarian cancer treatment.
Ontology highlight
ABSTRACT: Insights from basic science dissecting carcinogenesis in the fallopian tube and ovary have led to a deeper understanding of the origin, molecular characteristics, and types of ovarian cancers. This logically then has led to the development of novel approaches to treat ovarian cancer. Increasingly, novel agents are being developed to target the different growth pathways. The identification of molecular markers associated with different histopathologies has resulted in newer clinical trial designs to capture both clinical and translational endpoints. Unique molecular characteristics in DNA damage and repair pathways and unique cell surface markers have driven new drug development, yielding promise for both patients with platinum-sensitive and platinum-resistant ovarian cancers. Specific exam
SUBMITTER: Lee JM
PROVIDER: S-EPMC7437367 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA